Mesa Laboratories (MLAB)
(Delayed Data from NSDQ)
$128.43 USD
+2.28 (1.81%)
Updated Sep 19, 2024 03:59 PM ET
After-Market: $128.00 -0.43 (-0.33%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth D Momentum B VGM
Average Brokerage Rating
Current ABR | 2.50 |
ABR (Last week) | 2.50 |
# of Recs in ABR | 4 |
Average Target Price | $130.00 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 65 of 253 |
Current Quarter EPS Est: | 2.48 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 0 | 0 | 0 |
ABR | 2.50 | 2.50 | 1.67 | 1.67 | 1.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/27/2024 | Wells Fargo Securities | Brandon Couillard | Not Available | Strong Sell |
8/12/2024 | KeyBanc Capital Markets | Paul Knight | Hold | Hold |
8/6/2024 | Evercore Partners | Vijay Kumar | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.